A novel temporary prostatic stent for the relief of prostatic urethral obstruction

BJU International

Volumn 93, Issue 3, 2004, Pages 346-348

  Corica, A P ^a   Larson, B T ^b   Sagaz, A ^a   Corica, A G ^c   Larson, T R ^b  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b Institute of Medical Research Scottsdale   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

BPH; Continence; LUTS; Prostatic stent

Indexed keywords

ANESTHETIC AGENT;

AGED; ARTICLE; BALLOON; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FLOW RATE; HUMAN; MALE; MICTURITION; PRIORITY JOURNAL; PROSTATE DISEASE; QUALITY OF LIFE; SCORING SYSTEM; STENT; SYMPTOMATOLOGY; TOPICAL ANESTHESIA; URETHRA STENOSIS; URINE;

BALLOON DILATATION; EQUIPMENT DESIGN; HUMANS; MALE; PROSTATIC HYPERPLASIA; STENTS; URETHRAL OBSTRUCTION;

EID: 1342267559     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2003.04613.x     Document Type: Article

References (19)

1. Sonke GS, Kolman D, de la Rosette JJ, Donkers LH, Boyle P, Kiemeney LA. Prevalence of lower urinary tract symptoms in men and its influence on their quality of life. The Boxmeer Study. Ned Tijdschr Genteskd 2000; 144: 2558-63
2. Haidinger G, Temml C, Schatzl G et al. Risk factors for lower urinary tract symptoms in elderly men. For the Prostate Study Group of the Austrian Society of Urology. Eur Urol 2000; 37: 413-20
3. Haidinger G, Madersbacher S, Waldhoer T, Lunglmayr G, Vutuc C. The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables. Eur J Epidemiol 1999; 15: 717-22
4. Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999; 83: 410-5
5. Jacobsen SJ, Girman CJ, Lieber MM. Natural history of benign prostatic hyperplasia. Urology 2001; 58 (Suppl. 1): 5-16
6. Fabian KM. The intra-prostatic 'partial catheter' (urological spiral) (author's transl). Urologe A 1980; 19: 236-8
7. Fabian KM. The interprostatic 'partial catheter' (urologic spiral) II. Urologe A 1984; 23: 229-33
8. Nissenkorn I. The intraurethral catheter - three years of experience. Eur Urol 1993; 24: 27-30
9. Nissenkorn I, Slutzker D, Shalev M. Use of an intraurethral catheter instead of a Foley catheter after laser treatment of benign prostatic hyperplasia. Eur Urol 1996; 29: 341-4
10. de la Rosette JJ, Beerlage HP, Debruyne FM. Role of temporary stents in alternative treatment of benign prostatic hyperplasia. J Endourol 1997; 11: 467-72
11. Isotalo T, Talja M, Hellstrom P et al. A double-blind, randomized, placebo-controlled pilot study to investigate the effects of fmasteride combined with a biodegradable self-reinforced poly L-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from benign prostatic hyperplasia. BJU Int 2001; 88: 30-4
12. Isotalo T, Talja M, Valimaa T, Tormala P, Tammela TL. A bioabsorbable self-expandable, self-reinforced poly-L-lactic Acid urethral stent for recurrent urethral strictures: long-term results. J Endourol 2002; 16; 759-62
13. Laaksovirta S, Talja M, Valimaa T, Isotalo T, Tormala P, Tammela TL. Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent. J Urol 2001; 166: 919-22
14. Valimaa T, Laaksovirta S, Tammela TL et al. Viscoelastic memory and self-expansion of self-reinforced bioabsorbable stents. Biomaterials 2002; 23: 3575-82
15. Rosenkilde P, Pedersen JF, Meyhoff HH. Late complications of Prostakath treatment for benign prostatic hypertrophy. Br J Urol 1991; 68: 387-9
16. Gesenberg A, Sintermann R. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent. J Urol 1998; 160: 72-6
17. Badlani GH. Role of permanent stents. J Endourol 1997; 11: 473-5
18. Anjum MI, Chari R, Shetty A, Keen M, Palmer JH. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis. Br J Urol 1997; 80: 885-8
19. Bailey DM, Foley SJ, McFarlane JP, O'Neil G, Parkinson MC, Shah PJ. Histological changes associated with long-term urethral stents. Br J Urol 1998; 81: 745-9